SCHEMBL25459667

SCHEMBL25459667

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3ccc4c(c3)oc3cc(-c5ccc(-n6c7ccccc7c7ccccc76)c6oc7ccccc7c56)ccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.36
TSHR P16473 5/20 0.35
MAPT P10636 6/20 0.33
ALOX5 P09917 1/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 5/20 0.33
POLB P06746 2/20 0.33
HPGD P15428 1/20 0.33
PTGER4 P35408 1/20 0.33
HCRTR1 O43613 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
CDC14B O60729 1/20 0.32
CDC14A Q9UNH5 1/20 0.32
ALOX12 P18054 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24738659 1.00 PRKDC (0.36) PRKDCTSHRMAPTALOX5LMNA
SCHEMBL24738311 0.98 MAPT (0.35) PRKDCTSHRMAPTLMNAKDM4E
SCHEMBL24738649 0.97 PRKDC (0.34) PRKDCTSHRMAPTALOX5LMNA
SCHEMBL25458862 0.95 PRKDC (0.33) PRKDCTSHRMAPTALOX5LMNA
SCHEMBL24738682 0.95 MAPT (0.33) TSHRMAPTLMNAKDM4EHSD17B10
SCHEMBL24738681 0.94 MAPT (0.32) PRKDCTSHRMAPTLMNAKDM4E
SCHEMBL24740192 0.94 MAPT (0.32) PRKDCTSHRMAPTLMNAKDM4E
SCHEMBL25458759 0.93 PIM1 (0.33) PRKDCTSHRMAPTALDH1A1HPGD
SCHEMBL24739329 0.93 MAPT (0.33) PRKDCTSHRMAPTLMNAKDM4E
SCHEMBL24738740 0.93 PRKDC (0.35) PRKDCTSHRMAPTALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228523-A1 Metal complexes UDC IRELAND LTD (IE) 2024-07-11 US disclosed
US-20230331754-A1 MONONUCLEAR TRIPODAL HEXADENTATE IRIDIUM COMPLEXES FOR USE IN OLEDS UDC IRELAND LIMITED (IE) 2023-10-19 US disclosed
US-20230295104-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-09-21 US disclosed
US-20230157151-A1 ORGANIC ELECTROLUMINESCENT APPARATUS MERCK PATENT GMBH (DE) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331754-A1 MONONUCLEAR TRIPODAL HEXADENTATE IRIDIUM COMPLEXES FOR USE IN OLEDS OCIAD1, OCIAD2, NUDT1 PRKDC 2014/4885TSHR 3510/4885MAPT 2387/4885
US-20240228523-A1 Metal complexes MCU, IMMT, SOD1 PRKDC 2960/4885TSHR 3240/4885MAPT 1000/4885
US-20230295104-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, L1CAM, EPCAM PRKDC 3250/4885TSHR 4729/4885MAPT 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.